Planet 13 Holdings (PLNH) Profit After Tax Growth (3y) (2024 - 2026)
Planet 13 Holdings (PLNH) Profit After Tax Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | 14.01% |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 2.89% |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 8.71% |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | -34.81% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 15.37% |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 36.74% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Planet 13 Holdings | 47.95 Mn | 31.46 Mn | 12.32 Mn | -6.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.57% |
| Mar 31, 2026 | 1.53% |
| Dec 31, 2025 | 26.00% |
| Sep 30, 2025 | -86.85% |
| Jun 30, 2025 | -55.45% |
| Mar 31, 2025 | -21.24% |
| Dec 31, 2024 | -87.53% |
| Sep 30, 2024 | -6.64% |
| Jun 30, 2024 | 13.98% |
| Mar 31, 2024 | 15.22% |